Angiotensin I conversion and coronary constriction by angiotensin II in ischemic and hypoxic isolated rat hearts.

Angiotensin I conversion and coronary constriction by angiotensin II in ischemic and hypoxic isolated rat hearts.

Dose-response curves of angiotensin I (AI, 1.0-1000.0 pmol) and angiotensin II (AII, 1.25-1250.00 pmol) were obtained in isolated rat hearts subjected to control conditions, mild hypoxia (PO2 = 145 mm Hg), reoxygenation, ischemic (perfusion pressure = 35 mm Hg) and reperfusion. Both AI and AII cause...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Tian, R, Neubauer, S, Pulzer, F, Haas, U, Ertl, G
Natura:	Journal article
Lingua:	English
Pubblicazione:	1991

Documenti analoghi

Effects of endothelin-1 in the isolated heart under ischemic and cardioplegic conditions.
di: Neubauer, S, et al.
Pubblicazione: (1990)

Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.
di: Bauer, W, et al.
Pubblicazione: (1994)

Effects of endothelin-1 in isolated perfused rat heart.
di: Neubauer, S, et al.
Pubblicazione: (1990)

Increased availability of angiotensin AT 1 receptors leads to sustained arterial constriction to angiotensin II in diabetes - role for Rho-kinase activation.
di: Bagi, Z, et al.
Pubblicazione: (2011)

Deterioration of metabolic coronary regulation in hemorrhagic shock. Role of hypoxia and the renin-angiotensin system.
di: Ertl, G, et al.
Pubblicazione: (1985)

Interference of angiotensin-converting enzyme inhibition with vasoactive peptides in the coronary circulation of dogs.
di: Bauer, B, et al.
Pubblicazione: (1995)

Prevention with angiotensin-converting enzyme (ACE) inhibitors
di: Ertl, G, et al.
Pubblicazione: (1992)

[Prevention with angiotensin-converting enzyme (ACE) inhibitors]
di: Ertl, G, et al.
Pubblicazione: (1992)

High intraluminal pressure reduces AT1 receptor internalization and maintains arteriolar constrictions to angiotensin II
di: Koller, A, et al.
Pubblicazione: (2007)

Arterial hypertension and coronary heart disease: the place of angiotensin II receptor antagonists
di: E. O. Taratukhin
Pubblicazione: (2012-12-01)

Angiotensin-(1-7) improves the post-ischemic function in isolated perfused rat hearts
di: A.J. Ferreira, et al.
Pubblicazione: (2002-09-01)

Angiotensin Converting Enzyme and Angiotensin II Type 1 Receptor Polymorphisms in Patients with Coronary Aneurysms
di: Helbecque Nicole, et al.
Pubblicazione: (2003-08-01)

Angiotensin-(1-7) potentiates the coronary vasodilatatory effect of bradykinin in the isolated rat heart
di: A.P. Almeida, et al.
Pubblicazione: (2000-06-01)

Angiotensin II and the amygdala
di: Albrecht, D, et al.
Pubblicazione: (2003)

Angiotensin II antagonists
di: David García Barreto, et al.
Pubblicazione: (2014-03-01)

The polymorphisms in angiotensin-converting enzyme and angiotensin-converting enzyme 2 are not associated with thoracic aortic diseases and coronary heart disease
di: Yang Li, et al.
Pubblicazione: (2016-09-01)

Effects of endothelin-1 in the isolated heart in ischemia/reperfusion and hypoxia/reoxygenation injury.
di: Neubauer, S, et al.
Pubblicazione: (1991)

Recommendations for the clinical application of Angiotensin II receptor blocker in patients with coronary heart disease in 2018
di: Jianping Li, et al.
Pubblicazione: (2018-01-01)

Role of lipoxygenase products in the effects of angiotensin II in the isolated aorta and perfused heart of the rat
di: J. P. M. Dam, et al.
Pubblicazione: (1995-01-01)

Association Between the Angiotensin II/Angiotensin (1-7) Imbalance and Left Ventricular Hypertrophy in Patients with Heart Failure
di: Nikolov A., et al.
Pubblicazione: (2021-10-01)

Liraglutide attenuates cardiac remodeling and improves heart function after abdominal aortic constriction through blocking angiotensin II type 1 receptor in rats
di: Zheng RH, et al.
Pubblicazione: (2019-08-01)

Diminazene Aceturate Reduces Angiotensin II Constriction and Interacts with the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2
di: John M. Matsoukas, et al.
Pubblicazione: (2022-07-01)

Distinct Molecular Effects of Angiotensin II and Angiotensin III in Rat Astrocytes
di: Michelle A. Clark, et al.
Pubblicazione: (2013-01-01)

Tissue Angiotensin II Generating System by Angiotensin-Converting Enzyme and Chymase
di: Mizuo Miyazaki, et al.
Pubblicazione: (2006-01-01)

Angiotensin II for the treatment of vasodilatory shock: enough data to consider angiotensin II safe?
di: Nina Buchtele, et al.
Pubblicazione: (2018-04-01)

Angiotensin-Converting Enzyme Inhibitor Does Not Suppress Renal Angiotensin II Levels in Angiotensin I–Infused Rats
di: Keisuke Ohnishi, et al.
Pubblicazione: (2013-01-01)

Prognostic Impacts of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome Patients Without Heart Failure
di: Runzhen Chen, et al.
Pubblicazione: (2022-04-01)

ANGIOTENSIN II AND MYOCARDIAL INFARCTION
di: O. P. Shevchenko, et al.
Pubblicazione: (2016-01-01)

Role of angiotensin II in aging
di: Wenmin Yi, et al.
Pubblicazione: (2022-12-01)

The effects of adrenaline, angiotensin II, and its blocker on bovine coronary arteries
di: Ku Zaifah, Norsidah
Pubblicazione: (2003)

Use of Antihypertensive Drugs and Ischemic Stroke Severity - Is There a Role for Angiotensin-II?
di: Wen Yea Hwong, et al.
Pubblicazione: (2016-01-01)

Effects of Endogenous Angiotensin II on Abdominal Aortic Aneurysms and Atherosclerosis in Angiotensin II–Infused Mice
di: Masayoshi Kukida, et al.
Pubblicazione: (2021-05-01)

The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
di: Myla E. Moretti, et al.
Pubblicazione: (2012-01-01)

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19
di: Graham J. Moore, et al.
Pubblicazione: (2021-07-01)

Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock
di: Rinaldo Bellomo, et al.
Pubblicazione: (2020-02-01)

Lack of flow-mediated dilation and enhanced angiotensin II-induced constriction in skeletal muscle arterioles of lupus-prone autoimmune mice.
di: Bagi, Z, et al.
Pubblicazione: (2006)

Effect of angiotensin receptor blockers and angiotensin converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in dogs with heart disease
di: Éva Larouche‐Lebel, et al.
Pubblicazione: (2021-01-01)

Effect of angiotensin receptor blockers and angiotensin‐converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in cats with heart disease
di: Terry Huh, et al.
Pubblicazione: (2021-01-01)

Gene polymorphism of endothelial NO-synthase, angiotensin-converting enzyme and receptors of angiotensin II type 1 in patients with coronary artery disease and type II diabetes
di: Yakovleva L.M.
Pubblicazione: (2013-12-01)

Sex Differences in the Effectiveness of Angiotensin‐Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Sacubitril–Valsartan for the Treatment of Heart Failure
di: Zahra N. Sohani, et al.
Pubblicazione: (2023-07-01)